COVID Vaccines in Adolescents and Young Adults The Society for Adolescent Health and Medicine
JOURNAL OF ADOLESCENT HEALTH, cilt.70, sa.6, ss.1002-1005, 2022 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 70 Sayı: 6
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.jadohealth.2022.03.009
- Dergi Adı: JOURNAL OF ADOLESCENT HEALTH
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, ASSIA, PASCAL, CAB Abstracts, Child Development & Adolescent Studies, CINAHL, EMBASE, Gender Studies Database, MEDLINE, PAIS International, Psycinfo, Public Affairs Index, Social services abstracts, Sociological abstracts, Veterinary Science Database, Violence & Abuse Abstracts
- Sayfa Sayıları: ss.1002-1005
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Hacettepe Üniversitesi Adresli: Evet
Özet
Worldwide, a number of COVID-19 vaccines have been approved or granted Emergency Use Authorization (EUA) or Emergency Use Listing for adolescents and young adults (AYA), which has brought hope to many across the globe. Extension of the EUA for a COVID-19 vaccine to children and adolescents aged 5 through 15 years is exciting news for children, adolescents, parents, and providers of AYA. Many countries around the globe have extended immunization against COVID-19 to younger age groups. At the same time, the COVID-19 pandemic has led to a decrease globally in administration of other adolescent vaccines. This highlights that vaccine recommendations do not necessarily lead to successful and equitable vaccine distribution, and overcoming barriers to vaccination is critical. Certain subpopulations of AYA, particularly offered protection against all vaccine-preventable illnesses at every opportunity. Creating innovative strategies to improve vaccine uptake among AYA should be encouraged. (C) 2022 Society for Adolescent Health and Medicine. All rights reserved.